Tamoxifen

4-Hydroxytamoxifen is a first generation, selective estrogen receptor modulator (SERM) that functions as an antagonist in breast cancer cells but can display estrogen-like activities in the uterus and bone. Application 4-Hydroxytamoxifen may be

Application 4-Hydroxytamoxifen has been used: to induce the recombination of small intestinal organoids. to study its impact on the ability of human peripheral blood mononuclear cells (PMNCs) to form hematopoietic colonies.

Application 4-Hydroxytamoxifen has been used: to induce the recombination of small intestinal organoids. to study its impact on the ability of human peripheral blood mononuclear cells (PMNCs) to form hematopoietic colonies.

A 10 mM (2 mg/516 &#181L) sterile-filtered solution of (Z)-4-Hydroxytamoxifen in ethanol. A cell-permeable, active metabolite of Tamoxifen (Cat.

Application N -Desmethyltamoxifen HCl has been used as an internal standard in high-performance liquid chromatography (HPLC) for the quantification of metabolites from NG2 cell-derived astrocytes. Biochem/physiol Actions N-Desmethyltamoxifen HCl is

Application Refer to the product&#8242s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.

Tamoxifen is a Protein Kinase C inhibitor. It induces apoptosis in human malignant glioma cell lines.

Tamoxifen is a Protein Kinase C inhibitor. It induces apoptosis in human malignant glioma cell lines.

Tamoxifen is a Protein Kinase C inhibitor. It induces apoptosis in human malignant glioma cell lines.

Tamoxifen is a Protein Kinase C inhibitor. It induces apoptosis in human malignant glioma cell lines.